Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with short‐acting beta‐2 agonists (SABA) and anticholinergic bronchodilator medications, and both are recommended...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cochrane Database Syst Rev
Autori principali: Appleton, Sarah, Jones, Terry, Poole, Phillippa, Pilotto, Louis, Adams, Robert, Lasserson, Toby J, Smith, Brian J, Muhammed, Julia
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2006
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513456/
https://ncbi.nlm.nih.gov/pubmed/16625543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001387.pub2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi